Clarus Therapeutics Holdings Inc (CRXTW) Key Ratios
$0.01
As on 06-Sep-2022 15:49EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 0.97 | 45.74 | 119.14 | -- | -- |
| EBIT | 32.79 | -- | -- | -- | -- |
| Net Profit | 28.08 | 40.97 | -1,034.80 | -- | -- |
| EPS | 28.07 | 40.96 | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-21 | Dec-20 |
| EBIT-Margin
| -- | -- | -171.85 | -177.13 | -- |
| Net Margin
| -- | -- | -249.84 | -- | -- |
| Return on equity
| -- | -- | -- | 743.97 | -- |
| Return on Capital
| -- | -- | -- | -259.12 | -- |
| Return on Assets
| -- | -- | -44.53 | -73.06 | -- |
| Debt to Equity (x)
| -- | -- | 0.00 | -2.66 | -- |
The underlying data is unavailable.